Chiesi Enhances Asthma Portfolio with Acquisition of Atopix Therapeutics
by eazee-designstudio
Uromems closes €14m financing to develop its smart artificial urinary sphincter to market
Rigontec Appoints Dr. Jörg Vollmer as Chief Scientific Officer
Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies
The supervisory board of AYOXXA announces that Mr. Rodney Turner has assumed duties as interim CEO
